Diodes (NASDAQ:DIOD) Cut to “Buy” at Wall Street Zen

Wall Street Zen cut shares of Diodes (NASDAQ:DIOD) from a strong-buy rating to a buy rating in a research report report published on Saturday,Wall Street Zen reports.

Several other analysts have also commented on DIOD. Weiss Ratings reiterated a “hold (c)” rating on shares of Diodes in a report on Wednesday, July 15th. Zacks Research upgraded Diodes from a “hold” rating to a “strong-buy” rating in a research note on Friday, August 7th. Robert W. Baird set a $192.00 price target on Diodes in a research note on Thursday, August 6th. Finally, Truist Financial cut their price objective on shares of Diodes from $139.00 to $133.00 and set a “buy” rating on the stock in a report on Thursday, August 6th. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat, Diodes has an average rating of “Buy” and a consensus price target of $135.00.

Diodes Stock Performance

DIOD stock opened at $96.37 on Friday. The firm has a market cap of $4.44 billion, a price-to-earnings ratio of 52.09 and a beta of 1.89. The firm has a 50-day simple moving average of $92.32 and a two-hundred day simple moving average of $93.69. Diodes has a one year low of $42.28 and a one year high of $125.99. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.99 and a current ratio of 3.17.

Diodes (NASDAQ:DIOD) last issued its quarterly earnings data on Wednesday, August 5th. The semiconductor company reported $0.70 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.63 by $0.07. Diodes had a net margin of 5.27% and a return on equity of 4.33%. The firm had revenue of $445.53 million for the quarter, compared to the consensus estimate of $436.60 million. During the same quarter in the previous year, the firm earned $0.32 EPS. The company’s quarterly revenue was up 21.7% compared to the same quarter last year. Diodes has set its Q3 2026 guidance at 0.950-1.150 EPS. On average, equities analysts forecast that Diodes will post 3.15 EPS for the current fiscal year.

Institutional Investors Weigh In On Diodes

A number of large investors have recently bought and sold shares of the company. ProShare Advisors LLC lifted its position in shares of Diodes by 3.2% during the 4th quarter. ProShare Advisors LLC now owns 8,932 shares of the semiconductor company’s stock valued at $441,000 after buying an additional 274 shares in the last quarter. GAMMA Investing LLC grew its stake in Diodes by 8.9% in the 2nd quarter. GAMMA Investing LLC now owns 3,495 shares of the semiconductor company’s stock valued at $382,000 after acquiring an additional 287 shares during the period. Integrated Wealth Concepts LLC purchased a new stake in Diodes in the 2nd quarter worth $35,000. Easterly Investment Partners LLC increased its holdings in Diodes by 2.9% in the 4th quarter. Easterly Investment Partners LLC now owns 13,848 shares of the semiconductor company’s stock worth $683,000 after acquiring an additional 391 shares in the last quarter. Finally, QRG Capital Management Inc. raised its position in Diodes by 7.4% during the second quarter. QRG Capital Management Inc. now owns 6,341 shares of the semiconductor company’s stock worth $694,000 after acquiring an additional 436 shares during the period. Hedge funds and other institutional investors own 99.23% of the company’s stock.

About Diodes

Diodes Incorporated is a semiconductor manufacturer that develops, manufactures and sells discrete, analog, mixed-signal and logic products. Its portfolio includes rectifiers, diodes, transistors, power-management devices, voltage regulators, load switches, signal-integrity components, timing products and automotive-qualified semiconductor solutions.

The company’s products are used in power conversion, protection, switching, connectivity and signal-processing applications across the automotive, industrial, consumer electronics, computing, communications and healthcare markets.